Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung Cancer

Clinical trial NCT05991895 · UNKNOWN

Trial details

NCT number: NCT05991895
Sponsor: Jinming Yu
Status: UNKNOWN
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2023-07-24
Primary completion: 2026-07-01
Enrollment: 5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.